{
    "eid": "2-s2.0-85092075609",
    "title": "Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?",
    "cover-date": "2020-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (all)",
            "@code": "3000",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Antiviral treatment",
        "COVID-19",
        "Immunomodulation",
        "Macrolide",
        "SARS-CoV-2"
    ],
    "authors": [
        "Gerwyn Morris",
        "Eugene Athan",
        "Ken Walder",
        "Chiara C. Bortolasci",
        "Adrienne O'Neil",
        "Wolf Marx",
        "Michael Berk",
        "Andr\u00e9 F. Carvalho",
        "Michael Maes",
        "Basant K. Puri"
    ],
    "citedby-count": 6,
    "ref-count": 340,
    "ref-list": [
        "SARS-CoV-2 and viral sepsis: observations and hypotheses",
        "Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures",
        "A novel coronavirus from patients with pneumonia in China, 2019",
        "Temporal dynamics in viral shedding and transmissibility of COVID-19",
        "Association of cardiac Injury with mortality in hospitalized patients with COVID-19 in Wuhan, China",
        "Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China",
        "Pulmonary Post-mortem Findings in a Large Series of COVID-19 Cases From Northern Italy. medRxiv",
        "Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series From New Orleans. medRxiv",
        "Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer",
        "The Landscape of Lung Bronchoalveolar Immune Cells in COVID-19 Revealed by Single-cell RNA Sequencing. medRxiv",
        "Dysregulation of lung myeloid cells in COVID-19",
        "A pathological report of three COVID-19 cases by minimally invasive autopsies",
        "COVID-19: consider cytokine storm syndromes and immunosuppression",
        "COVID-19 Infection Induces Readily Detectable Morphological and Inflammation-Related Phenotypic Changes in Peripheral Blood Monocytes, the Severity of Which Correlate With Patient Outcome. medRxiv",
        "Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?",
        "Dysregulation of immune response in patients with COVID-19 in Wuhan, China",
        "COVID-19 infection: the perspectives on immune responses",
        "Aveolar macrophage activation and cytokine storm in the pathogenesis of severe COVID-19",
        "COVID-19: melatonin as a potential adjuvant treatment",
        "Detectable Serum SARS-CoV-2 Viral Load (RNAaemia) Is Closely Associated With Drastically Elevated Interleukin 6 (IL-6) Level in Critically Ill COVID-19 Patients",
        "Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity",
        "Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19",
        "The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients",
        "Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). medRxiv",
        "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
        "Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages",
        "SARS-CoV-2: a storm is raging",
        "Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions",
        "COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons",
        "Endothelial cell infection and endotheliitis in COVID-19",
        "Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection",
        "The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome",
        "Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N1",
        "Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19",
        "Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia",
        "The acute respiratory distress syndrome: from mechanism to translation",
        "The pathogenesis of sepsis and potential therapeutic targets",
        "The role of macrophages in the pathogenesis of ALI/ARDS",
        "Sepsis: inflammation is a necessary evil",
        "The immunopathology of sepsis and potential therapeutic targets",
        "Management of critically ill adults with COVID-19",
        "COVID-19 \u2013 what should anaethesiologists and intensivists know about it?",
        "Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: the importance of aftercare",
        "Risk factors at index hospitalization associated with longer-term mortality in adult sepsis survivors",
        "Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis",
        "Psychiatric morbidity in survivors of the acute respiratory distress syndrome: a systematic review",
        "Long-term psychiatric morbidities among SARS survivors",
        "Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms",
        "Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic",
        "COVID-19 fatigue: not so fast",
        "COVID-19 pneumonia: different respiratory treatments for different phenotypes?",
        "COVID-19 does not lead to a \u201ctypical\u201d acute respiratory distress syndrome",
        "Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)",
        "Potential effects of coronaviruses on the cardiovascular system",
        "Pathological findings of COVID-19 associated with acute respiratory distress syndrome",
        "COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options",
        "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study",
        "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",
        "The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19",
        "Clinical characteristics of coronavirus disease 2019 in China",
        "Viral load of SARS-CoV-2 in clinical samples",
        "SARS-CoV-2 viral load in upper respiratory specimens of infected patients",
        "The trinity of COVID-19: immunity, inflammation and intervention",
        "Effect of Dexamethasone in Hospitalized Patients With COVID-19: Preliminary Report. medRxiv",
        "Tocilizumab treatment in COVID-19: a single center experience",
        "Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",
        "Efficacy of Hydroxychloroquine in Patients With COVID-19: Results of a Randomized Clinical Trial. medRxiv",
        "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial",
        "Hydroxychloroquine Application Is Associated With a Decreased Mortality in Critically Ill Patients With COVID-19. medRxiv",
        "Effect of Hydroxychloroquine in Hospitalized Patients With COVID-19: Preliminary Results From a Multi-Centre, Randomized, Controlled Trial. medRxiv",
        "Observational study of hydroxychloroquine in hospitalized patients with COVID-19",
        "Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state",
        "Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19",
        "Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: a retrospective analysis",
        "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France",
        "Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases",
        "Azithromycin augments rhinovirus-induced IFN\u03b2 via cytosolic MDA5 in experimental models of asthma exacerbation",
        "Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis",
        "OP0191 all-cause mortality and cardiovascular death in hydroxychloroquine users in rheumatoid arthritis patients \u2013 a population based danish cohort study",
        "The immunomodulatory effects of macrolides\u2014a systematic review of the underlying mechanisms",
        "Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus",
        "Hydroxychloroquine for systemic lupus erythematosus in adults",
        "Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review",
        "The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus",
        "Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual",
        "Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort",
        "Longterm hydroxychloroquine therapy and low-dose aspirin may have an additive effectiveness in the primary prevention of cardiovascular events in patients with systemic lupus erythematosus",
        "The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus",
        "Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus",
        "Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis",
        "Twenty-year brain magnetic resonance imaging follow-up study in Systemic Lupus Erythematosus: factors associated with accrual of damage and central nervous system involvement",
        "KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis",
        "Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort",
        "Hydroxychloroquine use and risk of CKD in patients with rheumatoid arthritis",
        "Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study",
        "Systemic lupus erythematosus: from genes to organ damage",
        "FRI0356 organ damage in systemic lupus erythematosus is consistently associated with increased mortality: a meta-analysis",
        "Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus",
        "Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients",
        "Neurologic manifestations of systemic lupus erythematosus in children and adults",
        "Update on lupus nephritis",
        "New-onset non-infectious pulmonary manifestations among patients with systemic lupus erythematosus in Sweden",
        "Pulmonary manifestations in late versus early systemic lupus erythematosus: a systematic review and meta-analysis",
        "Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)",
        "Adherence to hydroxychloroquine improves long-term survival of patients with systemic lupus erythematosus",
        "Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort",
        "299 increased mortality among patients with systemic lupus erythematosus after hydroxychloroquine discontinuation",
        "Observational and interventional study design types; an overview",
        "Observational research\u2014opportunities and limitations",
        "Research methods in healthcare epidemiology and antimicrobial stewardship-quasi-experimental designs",
        "Threats to validity in retrospective studies",
        "Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks",
        "Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1",
        "Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy\u2013treated immunologic nonresponders",
        "Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1",
        "Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1",
        "Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases",
        "Nucleic acids and endosomal pattern recognition: how to tell friend from foe?",
        "Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines",
        "The role of antimalarial agents in the treatment of SLE and lupus nephritis",
        "Extracellular RNA sensing by pattern recognition receptors",
        "Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers",
        "Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort",
        "Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics",
        "Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sj\u00f6gren's syndrome in the JOQUER randomized trial",
        "Interferon targeted therapies in systemic lupus erythematosus",
        "Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus",
        "Therapeutic potential of hydroxychloroquine on serum B-cell activating factor belonging to the tumor necrosis factor family (BAFF) in rheumatoid arthritis patients",
        "Immunomodulatory effects of hydroxychloroquine on Th1/Th2 balance in women with repeated implantation failure",
        "Hydroxychloroquine inhibits the differentiation of Th17 cells in systemic lupus erythematosus",
        "Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset",
        "Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture",
        "Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice",
        "In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine",
        "Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK",
        "The pharmacokinetic and pharmacodynamic properties of hydroxychloroquine and dose selection for COVID-19: putting the cart before the horse",
        "Chloroquine is a potent inhibitor of SARS coronavirus infection and spread",
        "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)",
        "pH homeostasis of cellular organelles",
        "Endosome maturation",
        "Lysosomal acidification mechanisms",
        "The lysosome turns fifty",
        "Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc",
        "Golgi pH, ion and redox homeostasis: how much do they really matter?",
        "The pH of the secretory pathway: measurement, determinants, and regulation",
        "Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins",
        "Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen",
        "Organizational interplay of Golgi N-glycosyltransferases involves organelle microenvironment-dependent transitions between enzyme homo- and heteromers",
        "Elevated Golgi pH impairs terminalN-glycosylation by inducing mislocalization of Golgi glycosyltransferases",
        "The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function",
        "Structural basis for pH-dependent retrieval of ER proteins from the Golgi by the KDEL receptor",
        "Control systems of membrane transport at the interface between the endoplasmic reticulum and the Golgi",
        "Retrograde transport from the pre-Golgi intermediate compartment and the Golgi complex is affected by the vacuolar H+-ATPase inhibitor bafilomycin A1",
        "Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin",
        "Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials",
        "Pharmacology of chloroquine and hydroxychloroquine",
        "Hydroxychloroquine: a physiologically-based pharmacokinetic model in the context of cancer-related autophagy modulation",
        "Chloroquine transport via the malaria parasite's chloroquine resistance transporter",
        "The position of lysosomes within the cell determines their luminal pH",
        "Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells",
        "Defective acidification of intracellular organelles results in aberrant secretion of cathepsin D in cancer cells",
        "Interfering with endolysosomal trafficking enhances release of bioactive exosomes",
        "Lysosomal function and dysfunction: mechanism and disease",
        "Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein",
        "Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion",
        "Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells",
        "Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion",
        "Fusion rapidly follows vesicle transport to the target membrane in protein transport through the Golgi apparatus in vitro. A re-evaluation of transport kinetics based on the finding that the glycosylation used to mark transport, and not transport itself, is rate limiting in the assay. Molecular Mechanisms of Membrane Traffic",
        "Weakly basic amines inhibit the proteolytic conversion of proalbumin to serum albumin in cultured rat hepatocytes",
        "Two-pore channels regulate Tat endolysosome escape and Tat-mediated HIV-1 LTR transactivation",
        "Lysosome membrane permeabilization and disruption of the molecular target of rapamycin (mTOR)-lysosome interaction are associated with the inhibition of lung cancer cell proliferation by a chloroquinoline analog",
        "Lysosomal membrane permeabilization and cell death",
        "Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site",
        "Drugs targeting various stages of the SARS-CoV-2 life cycle: exploring promising drugs for the treatment of Covid-19",
        "A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells",
        "TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells",
        "Cell entry mechanisms of SARS-CoV-2",
        "Identification of a pH sensor in the furin propeptide that regulates enzyme activation",
        "Furin at the cutting edge: from protein traffic to embryogenesis and disease",
        "Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV",
        "Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner",
        "Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level",
        "Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19",
        "Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step",
        "Interplay between SARS-CoV-2 and the type I interferon response",
        "Membrane rearrangements mediated by coronavirus nonstructural proteins 3 and 4",
        "A molecular pore spans the double membrane of the coronavirus replication organelle",
        "Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2016)",
        "Severe acute respiratory syndrome: identification of the etiological agent",
        "Nidovirales: evolving the largest RNA virus genome",
        "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response",
        "The intracellular sites of early replication and budding of SARS-coronavirus",
        "Coronavirus envelope (E) protein remains at the site of assembly",
        "The YXX\u03a6 motif within the severe acute respiratory syndrome coronavirus (SARS-CoV) 3a protein is crucial for its intracellular transport",
        "Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein",
        "Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain",
        "Unexpected receptor functional mimicry elucidates activation of coronavirus fusion",
        "Subcellular localization and membrane association of SARS-CoV 3a protein",
        "Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Non-structural Proteins Identifies Unique and Shared Host-cell Dependencies. bioRxiv: The Preprint Server for Biology",
        "The Molecular Biology of Coronaviruses. Advances in Virus Research",
        "Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M",
        "Site-specific glycan analysis of the SARS-CoV-2 spike",
        "Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans",
        "The role of extracellular vesicles in COVID-19 virus infection",
        "Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells",
        "Host factors in coronavirus replication",
        "Coronavirus infection, ER stress, apoptosis and innate immunity",
        "SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes",
        "The endoplasmic reticulum stress response in neuroprogressive diseases: emerging pathophysiological role and translational implications",
        "Coronavirus nsp6 proteins generate autophagosomes from the endoplasmic reticulum via an omegasome intermediate",
        "Coronavirus NSP6 restricts autophagosome expansion",
        "Analysis of SARS-CoV-2-Controlled Autophagy Reveals Spermidine, MK-2206, and Niclosamide as Putative Antiviral Therapeutics",
        "Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis",
        "Digesting the crisis: autophagy and coronaviruses",
        "Autophagy inhibition mediates apoptosis sensitization in cancer therapy by relieving FOXO3a turnover",
        "Regulation of apoptosis by autophagy to enhance cancer therapy",
        "Targeting autophagy in cancer: update on clinical trials and novel inhibitors",
        "A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/Nab-paclitaxel in pancreatic cancer patients",
        "Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes",
        "New insights into the antiviral effects of chloroquine",
        "Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity",
        "The use of antimalarial drugs against viral infection",
        "Infection with MERS-CoV causes lethal pneumonia in the common marmoset",
        "An evaluation of chloroquine as a broad-acting antiviral against Hand",
        "Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial",
        "Chloroquine and hydroxychloroquine in the era of SARS - CoV2: caution on their cardiac toxicity",
        "Cardiac potassium channels: physiological insights for targeted therapy",
        "Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review",
        "Antimalarial-induced cardiomyopathy in systemic lupus erythematosus: as rare as considered?",
        "Factors affecting the electrocardiographic QT interval in malaria: a systematic review and meta-analysis of individual patient data",
        "The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review",
        "Hypoxia-inducible factor-1\u03b1 regulates microglial functions affecting neuronal survival in the acute phase of ischemic stroke in mice",
        "2019 update of the EULAR recommendations for the management of systemic lupus erythematosus",
        "Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening",
        "Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy",
        "New concepts in antimalarial use and mode of action in dermatology",
        "Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications",
        "Janus sword actions of chloroquine and hydroxychloroquine against COVID-19",
        "Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology",
        "Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis",
        "Pharmacokinetics and bioequivalence study of hydroxychloroquine sulfate tablets in Chinese healthy volunteers by LC-MS/MS",
        "Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report",
        "Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by <em>Plasmodium vivax",
        "Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension",
        "Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS",
        "In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses",
        "Optimizing hydroxychloroquine dosing for patients with COVID-19: an integrative modeling approach for effective drug repurposing",
        "Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro",
        "Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies",
        "Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance",
        "Unravelling the interplay between extracellular acidosis and immune cells",
        "Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12",
        "Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome",
        "Regulation of lysosomal ion homeostasis by channels and transporters",
        "Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates",
        "Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2. bioRxiv: The Preprint Server for Biology",
        "Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers",
        "Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation",
        "Azithromycin therapy for neutrophilic airways disease: myth or magic?",
        "Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen",
        "Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants",
        "Azithromycin inhibits nuclear factor-\u03baB activation during lung inflammation: an in vivo imaging study",
        "Inhibition of NF-\u03baB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival",
        "Transmissible gastroenteritis coronavirus induces programmed cell death in infected cells through a caspase-dependent pathway",
        "Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation",
        "Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5",
        "The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists",
        "Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis",
        "Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas",
        "Azithromycin polarizes macrophages to an M2 phenotype via inhibition of the STAT1 and NF-\u03baB signaling pathways",
        "Azithromycin alters macrophage phenotype",
        "Azithromycin promotes alternatively activated macrophage phenotype in systematic lupus erythematosus via PI3K/Akt signaling pathway",
        "Macrophage rewiring by nutrient associated PI3K dependent pathways",
        "Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages",
        "Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease",
        "Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin chronic obstructive pulmonary disease subjects",
        "Regulation of alveolar macrophage death in acute lung inflammation",
        "Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae",
        "Azithromycin reduces spontaneous and induced inflammation in \u0394F508 cystic fibrosis mice",
        "Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment",
        "Azithromycin induces in vitro a time-dependent increase in the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes without damaging phagocytes",
        "G-CSF and GM-CSF modify neutrophil functions at concentrations found in cystic fibrosis",
        "Macrolides inhibit epithelial cell\u2013mediated neutrophil survival by modulating granulocyte macrophage colony\u2013stimulating factor release",
        "Granulocyte macrophage-colony stimulating factor (GM-CSF) augments acute lung injury via its neutrophil priming effects",
        "Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF",
        "Azithromycin inhibits neutrophil accumulation in airways by affecting interleukin-17 downstream signals",
        "Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: a preliminary report",
        "Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection",
        "Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome",
        "Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential",
        "What drives neutrophils to the alveoli in ARDS?",
        "Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation",
        "Inflammasomes and pyroptosis as therapeutic targets for COVID-19",
        "Azithromycin use and outcomes in severe sepsis patients with and without pneumonia",
        "Adjunctive therapy with azithromycin for moderate and severe acute respiratory distress syndrome: a retrospective, propensity score-matching analysis of prospectively collected data at a single center",
        "Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis",
        "Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice",
        "Influence of adjunct azithromycin on the mortality of experimental Pseudomonas aeruginosa sepsis",
        "Azithromycin in combination with ceftriaxone reduces systemic inflammation and provides survival benefit in a murine model of polymicrobial sepsis",
        "Azithromycin for COVID-19: more than just an antimicrobial?",
        "Azithromycin induces anti-viral responses in bronchial epithelial cells",
        "Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells",
        "Azithromycin protects against zika virus infection by upregulating virus-induced type I and III interferon responses",
        "Imbalanced host response to SARS-CoV-2 drives development of COVID-19",
        "Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors",
        "SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Further Increased by a Naturally Occurring Elongation Variant. bioRxiv",
        "Coronavirus infections and immune responses",
        "Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells",
        "Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo",
        "Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection",
        "In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect",
        "Azithromycin and the risk of cardiovascular death",
        "Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials",
        "Systematic review, meta-analysis, and network meta-analysis of the cardiovascular safety of macrolides",
        "Effect of chloroquine, hydroxychloroquine, and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection",
        "Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine",
        "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)",
        "Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction",
        "Azithromycin and Ciprofloxacin Have a Chloroquine-like Effect on Respiratory Epithelial Cells. bioRxiv",
        "Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays",
        "Subcellular distribution of azithromycin and clarithromycin in rat alveolar macrophages (NR8383) in vitro",
        "Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes",
        "Phagocyte uptake and transport of azithromycin",
        "Advanced-generation macrolides: tissue-directed antibiotics",
        "Azithromycin\u2014spectrum of activity, pharmacokinetics, and clinical applications",
        "Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions",
        "The pharmacokinetics of azithromycin in human serum and tissues",
        "Azithromycin\u2014review of key chemical, pharmacokinetic and microbiological features",
        "Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg",
        "Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily",
        "Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin",
        "Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process",
        "Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial",
        "Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis",
        "SARS-CoV-2, SARS-CoV-1 and MERS-CoV Viral Load Dynamics, Duration of Viral Shedding and Infectiousness: A Living Systematic Review and Meta-analysis",
        "Viral dynamics in mild and severe cases of COVID-19",
        "Transmission of 2019-nCoV infection from an asymptomatic contact in Germany",
        "Virological assessment of hospitalized patients with COVID-2019",
        "Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms"
    ],
    "affiliation": [
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60026553",
            "affilname": "University of Melbourne",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60021050",
            "affilname": "Barwon Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021050",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Cambridge",
            "@id": "123102534",
            "affilname": "C.A.R.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123102534",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": [
        "NHMRC"
    ]
}